Pfizer to initiate US Phase I trial of PF-04217903 in Patients With Advanced Cancer

Posted on June 27, 2008 by crimsoncanary

Pfizer is to initiate a US Phase I trial of c-Met/HGFR kinase inhibitor PF-04217903 in patients with advanced tumors

Filed under: kinase | Tagged: , , , , , , | Comments Off

Exelixis and GlaxoSmithKline Conclude Six-Year Discovery and Development Collaboration

Posted on June 27, 2008 by crimsoncanary

Exelixis and GlaxoSmithKline will conclude their six-year collaboration in October 2008. GSK will have the right to choose one of the following compounds for for further development and commercialization: XL184, XL281, XL228, XL820, and XL844. GSK previously selected XL880 from the collaboration

Filed under: kinase | Tagged: , , , , | Comments Off